DOW JONES23,172.83+518.97 2.29%
S&P 5002,715.24+55.83 2.10%
NASDAQ8,032.58+145.32 1.84%

Benchmark Maintains Speculative Buy on Chembio Diagnostics, Lowers Price Target to $5

Benchmark maintains Chembio Diagnostics (NASDAQ:CEMI) with a Speculative Buy and lowers the price target from $9 to $5.

Benzinga · 03/04/2020 12:28

Benchmark maintains Chembio Diagnostics (NASDAQ:CEMI) with a Speculative Buy and lowers the price target from $9 to $5.